South Korea Car-T Cell Therapy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
South Korea Car-T Cell Therapy Market is Segmented By Targeted Antigen (CD19, CD20, BCMA, GCP-3, Claudin 18.2), By Therapeutic Application (B-cell non-Hodgkin\'s lymphoma, Multiple Myeloma, Cervical Cancer, Gastric Cancer, Lung Cancer, Others). The report offers the value (in USD Million) for the above-mentioned segments
South Korea Car-T Cell Therapy Market Size
Market Size in USD
CAGR16.1%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 16.1% |
| Market Concentration | Medium |
| Major Players | Novartis AG, Pfizer, Inc., Bristol Myers Squibb, CARsgen Therapeutics Co., Ltd., Fate Therapeutics, Inc. |
please let us know !
South Korea Car-T Cell Therapy Market Analysis
The South Korea Car-T Cell Therapy Market is estimated to be valued at USD 7.88 Mn in 2024 and is expected to reach USD 18.91 Mn by 2031, growing at a compound annual growth rate (CAGR) of 16.1% from 2024 to 2031.
With successful treatment of hematologic malignancies and rising investment by both public and private players in developing CAR-T therapies, the market is expected to witness steady growth.